BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 13, 2007
View Archived Issues
Carfilzomib well tolerated in consecutive-day schedule in hematologic malignancies
Read More
New preclinical and clinical data detail antithrombotic effects of YM-150
Read More
Novo Nordisk reports results for the third quarter 2007
Read More
Preclinical studies of anti-DKK1 mAb show potential for multiple myeloma therapy
Read More
Pooled trial data confirm eculizumab efficacy in paroxysmal nocturnal hemoglobinuria
Read More
Rivaroxaban thromboprophylaxis effective after hip replacement surgery
Read More
Bv8 promotes tumor growth through angiogenesis
Read More
New therapeutic agents for neurological disorders reported in recent patents
Read More
BioLineRx enters license agreement with Innovative Pharmaceutical Concepts for BL-5010
Read More
BioCancell reports successful experimental treatment using BC-819 for ovarian cancer
Read More
BioInvent designates BI-505 for blood cancer as new drug candidate
Read More
Astion Pharma initiates phase III clinical studies of ASF-1057 for seborrheic dermatitis
Read More
FDA grants approval to Resverlogix to initiate phase Ia clinical trial of RVX-208
Read More
Recent AstraZeneca and Argenta patents impart new therapeutic agents for respiratory disorders
Read More
Novel guanylate cyclase activators imparted in recent Bayer patent
Read More
ImmunoVaccine Technologies to acquire Immunotope
Read More
Mutant MOR gene transfer plus naloxone treatment leads to analgesia without tolerance in mice
Read More
Targacept initiates phase I clinical trial of TC-6499 for neuropathic pain
Read More
AVANIR initiates enrollment in phase III trial of Zenvia for pseudobulbar affect
Read More
Dia-B Tech reports positive results from phase I clinical study of ISF-402 for type 2 diabetes
Read More
Cobalamin oral insulin significantly reduces glucose in preclinical study
Read More
FDA grants orphan drug designation to GTC Biotherapeutics' ATryn
Read More
Wyeth Pharmaceuticals initiates phase I/II clinical trial of Trubion's TRU-015 for NHL
Read More
Celsion refiles for an FDA Special Protocol Assessment for phase III trial of ThermoDox
Read More
Medarex and Bristol-Myers report positive results from three registrational trials of ipilimumab
Read More
FDA grants approval to SKCC for phase I clinical trial of breast cancer vaccine
Read More
FDA advisory committee recommends approval of Kynapid for acute atrial fibrillation
Read More
Ono and Banyu submit Japanese approval application for sitagliptin for type 2 diabetes
Read More